Florida judge greenlights healthcare reform suit, involving 20 states

“The Patient Protection and Affordable Care Act (PPACA), amended by the HealthCare and Education Reconciliation Act of 2010 is a controversial and polarizing law about which reasonable and intelligent people can disagree in good faith,” said Roger Vinson, senior U.S. District Judge, beginning his Oct. 14 ruling in favor of allowing 20 states to move forward with a challenge to the constitutionality of President Barack Obama's healthcare reform legislation.

In his memorandum, Vinson said he is charged with deciding if the PPACA is constitutional or not, and he ultimately denied the motion to dismiss the case in which 20 states, led by Florida Attorney General Bill McCollum, sued the federal government. The case questions PPACA’s constitutionality via the Commerce Clause.

Vinson concluded that the individual mandate is not a tax as the Department of Justice has argued, mostly because Congress called it a penalty and knew how to enact a tax if it so desired. "Rather, it is based solely on citizenship and on being alive. ... The plaintiffs have most definitely stated a plausible claim with respect to this cause of action," wrote Vinson.

“At this stage in the litigation, this is not even a close call,” stated Vinson. “This case law is instructive, but ultimately inconclusive because the Commerce Clause and Necessary and Proper Clause have never been applied in such a manner before. The power that the individual mandate seeks to harness is simply without prior precedent.

“Of course, to say that something is ‘novel’ and ‘unprecedented’ does not necessarily mean that it is ‘unconstitutional’ and ‘improper.’ But, at this stage of the case, the plaintiffs have most definitely stated a plausible claim with respect to this cause of action,” Vinson continued.

Vinson found no ripeness concern because injury is certainly impending and harm will be felt in the immediate or near future.

McCollum, on his website, said this decision is "only the first step of a very long journey to overturning this … new law, but I am committed to continuing to lay the groundwork for our case’s success in my final months as Florida’s Attorney General. We hope to again prevail at the summary judgment hearing set for December.”

A copy of the ruling can be obtained here. Additional information about the healthcare lawsuit can be found here.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.